BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20730493)

  • 1. Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.
    Sakurada T; Takada S; Eguchi H; Izumi K; Satoh N; Ueda S
    Pharm World Sci; 2010 Dec; 32(6):737-43. PubMed ID: 20730493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment.
    Takahashi M; Ohara T; Yamanaka H; Shimada A; Nakaho T; Makoto Y
    Palliat Med; 2003 Dec; 17(8):673-8. PubMed ID: 14694918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
    Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
    Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.
    Hoffman M; Xu JC; Smith C; Fanelli C; Pascal V; Degaetano C; Meenan G; Lehrer M; Lesser M; Citron M
    Cancer Invest; 1997; 15(6):542-7. PubMed ID: 9412659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.
    van Dongen RT; Crul BJ; Koopman-Kimenai PM; Vree TB
    Br J Clin Pharmacol; 1994 Sep; 38(3):271-3. PubMed ID: 7826830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.
    Andersen G; Sjøgren P; Hansen SH; Jensen NH; Christrup L
    Eur J Pain; 2004 Jun; 8(3):263-71. PubMed ID: 15109977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine, morphine-6-glucuronide, and morphine-3-glucuronide in cerebrospinal fluid and plasma after epidural administration of morphine.
    Kalman S; Metcalf K; Eintrei C
    Reg Anesth; 1997; 22(2):131-6. PubMed ID: 9089854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
    Smith GD; Smith MT
    Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.
    Skarke C; Darimont J; Schmidt H; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2003 Jan; 73(1):107-21. PubMed ID: 12545149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
    Klepstad P; Kaasa S; Borchgrevink PC
    Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
    Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum of oncological patients after administration of morphine drugs.
    Netriova J; Blahova E; Johanesova Z; Brandsteterova E; Lehotay J; Serdt K; Mocak J
    Pharmazie; 2006 Jun; 61(6):528-34. PubMed ID: 16830402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: a pilot study.
    McCann S; Yaksh TL; von Gunten CF
    J Opioid Manag; 2010; 6(2):87-94. PubMed ID: 20481173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients.
    Gretton SK; Ross JR; Rutter D; Sato H; Droney JM; Welsh KI; Joel S; Riley J
    J Pain Symptom Manage; 2013 Apr; 45(4):670-80. PubMed ID: 22995672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
    Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.